Blood Salvage and Autotransfusion with Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence after Liver Transplantation for Advanced Hepatocellular Carcinoma

Annals of Surgery

Volumn 276, Issue 6, 2022, Pages E842-E850

  Kwon, Ji Hye ^a   Han, Sangbin ^a   Kim, Doyeon ^a   Kuk, Joon Hee ^a   Cho, Hyun ^b   Kim, Seonwoo ^b   Yang, Ju Dong ^c   Kim, Chul ^d   Kim, Jong Man ^a   Choi, Gyu Sung ^a   Joh, Jae Won ^a   Ko, Justin S ^a   Gwak, Mi Sook ^a   Kim, Gaabsoo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

autologous; blood transfusion; filtration; immunomodulation; leukocyte reduction; locoregional neoplasm; patient blood management; recurrences

Indexed keywords

BASILIXIMAB; ENTECAVIR; HEPATITIS B ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; TACROLIMUS;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; CANCER PATIENT; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOREDUCTION; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SAFETY; PROPENSITY SCORE; EPIDEMIOLOGY; LIVER TUMOR; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85141894512     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000004866     Document Type: Article

References (40)

1. Klein HG, Spahn DR, Carson JL,. Red blood cell transfusion in clinical practice. Lancet. 2007; 370: 415-426.
2. Smith NK, Kim S, Hill B,. Transfusion-related acute lung injury (TRALI) and transfusion-Associated circulatory overload (TACO) in liver transplantation: A case report and focused review. Semin Cardiothorac Vasc Anesth. 2018; 22: 180-190.
3. Hendrickson JE, Hillyer CD,. Noninfectious serious hazards of transfusion. Anesth Analg. 2009; 108: 759-769.
4. Han S, Choi GS, Kim JM,. Macrosteatotic and nonmacrosteatotic grafts respond differently to intermittent hepatic inflow occlusion: Comparison of recipient survival. Liver Transpl. 2015; 21: 644-651.
5. Han S, Kwon JH, Jung SH,. Perioperative fresh red blood cell transfusion may negatively affect recipient survival after liver transplantation. Ann Surg. 2018; 267: 346-351.
6. Kwon JH, Han S, Jang JS,. Decrease in the risk of post-Transplant hepatocellular carcinoma recurrence after the conversion to prestorage leukoreduction for transfused red blood cells. Transplantation. 2021; 105: 577-585.
7. Lee KW, Han S, Lee S,. Higher risk of posttransplant liver graft failure in male recipients of female donor grafts might not be due to anastomotic size disparity. Transplantation. 2018; 102: 1115-1123.
8. Spahn DR, Goodnough LT,. Alternatives to blood transfusion. Lancet. 2013; 381: 1855-1865.
9. Ashworth A, Klein AA,. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth. 2010; 105: 401-416.
10. Waters JH, Donnenberg AD,. Blood salvage and cancer surgery: should we do it? Transfusion. 2009; 49: 2016-2018.
11. Kumar N, Chen Y, Zaw AS,. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: A systematic review. Lancet Oncol. 2014; 15: e33-e41.
12. Muscari F, Suc B, Vigouroux D,. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int. 2005; 18: 1236-1239.
13. Akbulut S, Kayaalp C, Yilmaz M,. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol. 2013; 19: 1625-1631.
14. Gwak MS, Lee KW, Kim SY,. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transpl. 2005; 11: 331-335.
15. Han S, Kim G, Ko JS,. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg. 2016; 264: 339-343.
16. Kim JM, Kim GS, Joh JW,. Long-Term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int. 2013; 26: 84-89.
17. Liang TB, Li DL, Liang L,. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation. 2008; 85: 863-869.
18. Chun S, Phan MT, Hong S,. Double-filtered leukoreduction as a method for risk reduction of transfusion-Associated graft-versus-host disease. PLoS One. 2020; 15: e0229724.
19. Han S, Yang JD, Sinn DH,. Risk of post-Transplant hepatocellular carcinoma recurrence is higher in recipients of livers from male than female living donors. Ann Surg. 2018; 268: 1043-1050.
20. Duvoux C, Roudot-Thoraval F, Decaens T,. Liver transplantation for hepatocellular carcinoma: A model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012; 143: 986-994. e983; quiz e914-985.
21. Han S, Lee S, Yang JD,. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation. Liver Transpl. 2018; 24: 44-55.
22. Pruthi J, Medkiff KA, Esrason KT,. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl. 2001; 7: 811-815.
23. Choi ES, Ahn WS, Lee JM,. A laboratory study of the effects of processing blood through a cell salvage device and leucocyte depletion filter on levels of pro-inflammatory cytokines and bradykinin. Anaesthesia. 2013; 68: 1259-1265.
24. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94: 496.
25. Austin PC,. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2013; 32: 2837-2849.
26. D'Agostino RB Jr., Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17: 2265-2281.
27. Yao FY, Ferrell L, Bass NM,. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001; 33: 1394-1403.
28. Mazzaferro V, Llovet JM, Miceli R,. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol. 2009; 10: 35-43.
29. Zhai B, Sun XY,. Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients. World J Gastroenterol. 2013; 19: 3371-3374.
30. Clavien PA, Lesurtel M, Bossuyt PM,. Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report. Lancet Oncol. 2012; 13: e11-e22.
31. Vitale A, Volk M, Cillo U,. Transplant benefit for patients with hepatocellular carcinoma. World J Gastroenterol. 2013; 19: 9183-9188.
32. Fujimoto J, Okamoto E, Yamanaka N,. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg. 1993; 128: 1065-1069.
33. Kumar N, Ravikumar N, Tan JYH,. Current Status of the Use of Salvaged Blood in Metastatic Spine Tumour Surgery. Neurospine. 2018; 15: 206-215.
34. Kumar N, Zaw AS, Khoo BL,. Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells. Eur Spine J. 2016; 25: 4008-4015.
35. Karczewski DM, Lema MJ, Glaves D,. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth Analg. 1994; 78: 1131-1135.
36. Catling S, Williams S, Freites O,. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia. 2008; 63: 1332-1338.
37. Fidler IJ,. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3: 453-458.
38. Gharehbaghian A, Haque KM, Truman C,. Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency. Lancet. 2004; 363: 1025-1030.
39. Dzik S,. Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. Transfus Med Rev. 1993; 7: 65-77.
40. Bababekov YJ, Stapleton SM, Mueller JL,. A proposal to mitigate the consequences of type 2 error in surgical science. Ann Surg. 2018; 267: 621-622.